首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cardiovascular therapeutics

缩写:CARDIOVASC THER

ISSN:1755-5914

e-ISSN:1755-5922

IF/分区:3.4/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引947
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Robert W V Flynn,Thomas M MacDonald,Gordon D Murray et al. Robert W V Flynn et al.
Patients with intracerebral hemorrhage frequently have indications for antithrombotic therapy. This represents a therapeutic dilemma as intracerebral hemorrhage is considered a contraindication to antithrombotic medication. Previous systema...
Giuliana Mombelli,Franco Pazzucconi,Alighiero Bondioli et al. Giuliana Mombelli et al.
Some recent clinical reports have suggested that paradoxical decreases in high-density lipoprotein cholesterol (HDL-C) levels after fenofibrate treatment may be quite common. These appear to occur mainly in patients with combined fibrate/st...
Takashi Masuda,Misao N Ogura,Tatsumi Moriya et al. Takashi Masuda et al.
It has been proved that cilnidipine has N-type calcium channels inhibitory activity as well as L-type calcium channels and inhibits excessive release of norepinephrine from the sympathetic nerve ending. This study was undertaken to compare ...
Martin Stockburger,Alice Krebs,Oezlem Celebi et al. Martin Stockburger et al.
Evidence-based treatment for heart failure (HF) comprises beta-blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and aldosterone receptor antagonists (ARA). Diuretics (DR) are prescribed in acute and chronic...
Ying-Hong Wang,Jules I Schwartz,Wen-Lin Luo et al. Ying-Hong Wang et al.
Laropiprant is a selective antagonist of the prostaglandin D2 receptor subtype 1, and is primarily eliminated via glucuronidation with a minor contribution from oxidative metabolism via CYP3A. The effects of multiple oral doses of clarithro...
M Turiel,L Tomasoni,S Sitia et al. M Turiel et al.
Rheumatoid arthritis (RA) is associated with enhanced atherosclerosis and impaired endothelial function early after the onset of the disease and cardiovascular (CV) disease represents one of the leading causes of morbidity and mortality. It...
Henry Krum,John J V McMurray,Edward Horton et al. Henry Krum et al.
The Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial is exploring two pharmacological strategies (nateglinide and valsartan, both alone and in combination) in the prevention of overt diabetes mellitus...
Kwok M Ho,John P Lewis Kwok M Ho
Atrial fibrillation (AF) is very common within the first 5 days of cardiac surgery. It is associated with significant morbidity including stroke, ventricular arrhythmias, myocardial infarction, heart failure, acute kidney injury, prolonged ...
Osman Najam,Nizar Yonan,Simon G Williams et al. Osman Najam et al.
Following cardiac transplantation, registry data has demonstrated a gradual improvement in survival over the last several decades, which is testament to continual improvement in aftercare strategy. However, a significant number of patients ...
Jeremy A Schafer,Nicole K Kjesbo,Patrick P Gleason Jeremy A Schafer
Atrial fibrillation (AF) is the most common sustained arrhythmia, affecting more than 2.2 million Americans. ACC/AHA/ESC guidelines for the management of patients with AF recommend amiodarone for maintaining sinus rhythm. Dronedarone is a d...